Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boulder, CO
SEC filing record 1 source field available
Fiscal year end
31 December
Clovis Oncology, Inc. has filed 952 SEC EDGAR filings since 25 Jun 2009

SEC filing history

Showing 701-725 of 951 matching filings.

Per page
25
Current page
29
SC 13G File 005-86488

13G

Filing date
18 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-86488

SC 13G

Filing date
17 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86488

SC 13G/A

Filing date
17 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86488

SC 13G/A

Filing date
17 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86488

SC 13G/A filing

Filing date
13 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-86488

CLVS AS OF 12/31/2014

Filing date
12 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-86488

SC 13G filing

Filing date
02 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-86488

SCHEDULE 13G

Filing date
26 Jan 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
21 Jan 2015
Reporting date
15 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Jan 2015
Reporting date
16 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Jan 2015
Reporting date
15 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jan 2015
Reporting date
13 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
POSASR File 333-192416

POSASR

Filing date
26 Nov 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35347

CLOVIS ONCOLOGY, INC. 8-K

Filing date
06 Nov 2014
Reporting date
06 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35347

FORM 8-K

Filing date
09 Sep 2014
Reporting date
09 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35347

8-K

Filing date
04 Sep 2014
Reporting date
03 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35347

8-K

Filing date
02 Sep 2014
Reporting date
02 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-198022

FORM S-8

Filing date
11 Aug 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35347

CLOVIS ONCOLOGY, INC. 8-K

Filing date
07 Aug 2014
Reporting date
07 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Jun 2014
Reporting date
12 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Jun 2014
Reporting date
12 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35347

FORM 8-K

Filing date
16 Jun 2014
Reporting date
12 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jun 2014
Reporting date
12 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .